Article
Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
Transplantation - 1 Nov 2017
Abaalkhail Faisal, Elsiesy Hussein, Elbeshbeshy Hany, Shawkat Mohamed, Yousif Sarra, Ullah Waheed, Alabbad Saleh, Al-Jedai Ahmed, Ajlan Aziza, Broering Dieter, Saab Sammy, Al Sebayel Mohammed, Al-Hamoudi Waleed
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma and the leading indication for liver transplantation. In the Middle East, genotype 4 HCV infection is the most common genotype. However, limited data exists on the treatment of genotype-4 in the liver transplant setting. We evaluated the safety and efficacy of ledipasvir (LDV)-sofosbuvir (SOF) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.